Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription


3 BMC Cancer
6 BMC Gastroenterol
1 Cancer Res
3 Dig Dis Sci
3 Eur Radiol
1 Gastroenterology
1 Gastrointest Endosc
1 Gut
6 Hepatology
1 Int J Cancer
2 J Gastroenterol Hepatol
10 J Hepatol
1 Transplant Proc
2 Transplantation

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Cancer

  1. ZOU W, Wang Z, Wang F, Li L, et al
    A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
    BMC Cancer. 2021;21:608.
    PubMed         Abstract available

  2. HE D, Liao S, Cai L, Huang W, et al
    Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma.
    BMC Cancer. 2021;21:599.
    PubMed         Abstract available

  3. CHEN Y, Yang X, Chen Y, Chen G, et al
    Impacts of the SOAT1 genetic variants and protein expression on HBV-related hepatocellular carcinoma.
    BMC Cancer. 2021;21:615.
    PubMed         Abstract available

    BMC Gastroenterol

  4. SHENG G, Xie Q, Wang R, Hu C, et al
    Waist-to-height ratio and non-alcoholic fatty liver disease in adults.
    BMC Gastroenterol. 2021;21:239.
    PubMed         Abstract available

  5. ONO Y, Kariya S, Nakatani M, Ueno Y, et al
    Subcapsular hepatic hematoma: a case of chronic expanding hematoma of the liver.
    BMC Gastroenterol. 2021;21:241.
    PubMed         Abstract available

  6. XU L, Liu B, Liu Z, Tang N, et al
    Co-occurrence of Wilson's disease and systemic lupus erythematosus: a case report and literature review.
    BMC Gastroenterol. 2021;21:229.
    PubMed         Abstract available

  7. HE Y, Liang T, Mo S, Chen Z, et al
    Effect of timing of surgical resection of primary hepatocellular carcinoma on survival outcomes in elderly patients and prediction of clinical models.
    BMC Gastroenterol. 2021;21:230.
    PubMed         Abstract available

  8. BI Y, Shi X, Ren J, Yi M, et al
    Clinical outcomes of doxorubicin-eluting CalliSpheres(R) beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma.
    BMC Gastroenterol. 2021;21:231.
    PubMed         Abstract available

  9. LI Y, Liu X, Jiang Y, Wan K, et al
    Low preoperative prealbumin predicts the prevalence of complications following liver transplantation.
    BMC Gastroenterol. 2021;21:233.
    PubMed         Abstract available

    Cancer Res

  10. ZHAO Z, Gad H, Benitez-Buelga C, Sanjiv K, et al
    NEIL3 prevents senescence in hepatocellular carcinoma by repairing oxidative lesions at telomeres during mitosis.
    Cancer Res. 2021 May 27. pii: 0008-5472.CAN-20-1028.
    PubMed         Abstract available

    Dig Dis Sci

  11. LI X, Lv J, Hou L, Guo X, et al
    Circ_0001955 Acts as a miR-646 Sponge to Promote the Proliferation, Metastasis and Angiogenesis of Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 May 22. pii: 10.1007/s10620-021-07053.
    PubMed         Abstract available

  12. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    PubMed         Abstract available

  13. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
    Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
    Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
    PubMed         Abstract available

    Eur Radiol

  14. STOCKER D, Hectors S, Bane O, Vietti-Violi N, et al
    Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.
    Eur Radiol. 2021 May 27. pii: 10.1007/s00330-021-08068.
    PubMed         Abstract available

  15. CHOI SH, Jeon SK, Lee SS, Lee JM, et al
    Radio-pathologic correlation of biphenotypic primary liver cancer (combined hepatocellular cholangiocarcinoma): changes in the 2019 WHO classification and impact on LI-RADS classification at liver MRI.
    Eur Radiol. 2021 May 26. pii: 10.1007/s00330-021-07984.
    PubMed         Abstract available

  16. KIM PH, Hwang J, Yoon HM, Shin HJ, et al
    Outcome of staging chest CT and identification of factors associated with lung metastasis in children with hepatoblastoma.
    Eur Radiol. 2021 May 25. pii: 10.1007/s00330-021-08047.
    PubMed         Abstract available


  17. EDWARDS LA, Goldenberg SD, Shawcross DL
    Meeting the challenge of antimicrobial resistance in cirrhosis: the invisible threat that lies within.
    Gastroenterology. 2021 May 25. pii: S0016-5085(21)03065.

    Gastrointest Endosc

  18. LEUNG K, Jawaid N, Bollegala N
    Gender differences in gastroenterology and hepatology authorship and editorial boards.
    Gastrointest Endosc. 2021 May 21. pii: S0016-5107(21)01356.
    PubMed         Abstract available


  19. SUN J, Wu G, Pastor F, Rahman N, et al
    RNA helicase DDX5 enables STAT1 mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytes.
    Gut. 2021 May 21. pii: gutjnl-2020-323126. doi: 10.1136/gutjnl-2020-323126.
    PubMed         Abstract available


  20. JOHN BV, Deng Y, Martin P, Levy C, et al
    Response to "Is Male Gender Associated with Increased Liver-related Mortality in Primary Biliary Cholangitis and Cirrhosis?"
    Hepatology. 2021 May 22. doi: 10.1002/hep.31917.
    PubMed         Abstract available

  21. SUN LY, Hu JY, Liang L, Tong XM, et al
    Letter to the Editor: Is Male Gender Associated with Increased Liver-related Mortality in Primary Biliary Cholangitis and Cirrhosis?
    Hepatology. 2021 May 22. doi: 10.1002/hep.31916.
    PubMed         Abstract available

  22. YI C, Chen L, Ling Z, Liu L, et al
    Lenvatinib Targets FGFR4 to Enhance Antitumor Immune Response of Anti-PD-1 in Hepatocellular Carcinoma.
    Hepatology. 2021 May 26. doi: 10.1002/hep.31921.
    PubMed         Abstract available

  23. JOHNSTON ME 2ND, Rivas MP, Nicolle D, Gorse A, et al
    Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient Derived Xenograft Models.
    Hepatology. 2021 May 26. doi: 10.1002/hep.31919.
    PubMed         Abstract available

  24. LEPORE A, Choy PM, Lee NC, Carella MA, et al
    Phosphorylation and stabilization of PIN1 by JNK promote intrahepatic cholangiocarcinoma growth.
    Hepatology. 2021 May 28. doi: 10.1002/hep.31983.
    PubMed         Abstract available

  25. VIVEIROS A, Schaefer B, Panzer M, Henninger B, et al
    MRI-based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of non-HFE Hemochromatosis Genes.
    Hepatology. 2021 May 28. doi: 10.1002/hep.31982.
    PubMed         Abstract available

    Int J Cancer

  26. LONG L, Liu X, Jin L, Simon T, et al
    Association of bowel movement frequency and laxative use with risk of hepatocellular carcinoma in US women and men.
    Int J Cancer. 2021 May 24. doi: 10.1002/ijc.33699.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  27. TAK KY, Jang B, Lee SK, Nam HC, et al
    The prognostic role of M2BPGi compared with the HAP score in hepatocellular carcinoma patients receiving transarterial treatment.
    J Gastroenterol Hepatol. 2021 May 24. doi: 10.1111/jgh.15553.
    PubMed         Abstract available

  28. MA HL, Chen SD, Zheng KI, Yu Y, et al
    The TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2021 May 24. doi: 10.1111/jgh.15554.
    PubMed         Abstract available

    J Hepatol

  29. JALAN R, Szabo G
    New concepts and perspectives in decompensated cirrhosis.
    J Hepatol. 2021;75 Suppl 1:S1-S2.

  30. FERNANDEZ J, Piano S, Bartoletti M, Wey EQ, et al
    Management of bacterial and fungal infections in cirrhosis: The MDRO challenge.
    J Hepatol. 2021;75 Suppl 1:S101-S117.
    PubMed         Abstract available

  31. CARACENI P, Abraldes JG, Gines P, Newsome PN, et al
    The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery.
    J Hepatol. 2021;75 Suppl 1:S118-S134.
    PubMed         Abstract available

  32. GARCIA-PAGAN JC, Francoz C, Montagnese S, Senzolo M, et al
    Management of the major complications of cirrhosis: Beyond guidelines.
    J Hepatol. 2021;75 Suppl 1:S135-S146.
    PubMed         Abstract available

  33. JALAN R, D'Amico G, Trebicka J, Moreau R, et al
    New clinical and pathophysiological perspectives defining the trajectory of cirrhosis.
    J Hepatol. 2021;75 Suppl 1:S14-S26.
    PubMed         Abstract available

  34. TANDON P, Montano-Loza AJ, Lai JC, Dasarathy S, et al
    Sarcopenia and frailty in decompensated cirrhosis.
    J Hepatol. 2021;75 Suppl 1:S147-S162.
    PubMed         Abstract available

  35. JEPSEN P, Younossi ZM
    The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs.
    J Hepatol. 2021;75 Suppl 1:S3-S13.
    PubMed         Abstract available

  36. ENGELMANN C, Claria J, Szabo G, Bosch J, et al
    Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction.
    J Hepatol. 2021;75 Suppl 1:S49-S66.
    PubMed         Abstract available

  37. TREBICKA J, Macnaughtan J, Schnabl B, Shawcross DL, et al
    The microbiota in cirrhosis and its role in hepatic decompensation.
    J Hepatol. 2021;75 Suppl 1:S67-S81.
    PubMed         Abstract available

  38. VAN DER MERWE S, Chokshi S, Bernsmeier C, Albillos A, et al
    The multifactorial mechanisms of bacterial infection in decompensated cirrhosis.
    J Hepatol. 2021;75 Suppl 1:S82-S100.
    PubMed         Abstract available

    Transplant Proc

  39. KRAPF J, Schuhbeck A, Wendel T, Fritz J, et al
    Assessment of the Clinical Impact of a Liver-Specific, BCAA-Enriched Diet in Major Liver Surgery.
    Transplant Proc. 2021;53:624-629.
    PubMed         Abstract available


  40. GORGEN A, Sapisochin G
    Re: Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume.
    Transplantation. 2021;105:e64.

  41. SERENARI M, Ravaioli M, Cescon M
    Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume.
    Transplantation. 2021;105:e63.

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.